lusutrombopag sold brand name mulpleta among others medication developed certain conditions lead thrombocytopenia abnormally low platelet counts thrombocytopenia associated chronic liver disease patients prior elective invasive manufactured marketed japan approved us food drug administration fda july nice january approved medical use european union february drug article relating blood blood forming organs stub help wikipedia expanding httpsenwikipediaorgwikilusutrombopag